Literature DB >> 227787

Intracellular localization of the dermonecrotic toxin of Bordetella pertussis.

J L Cowell, E L Hewlett, C R Manclark.   

Abstract

Localization of the heat-labile dermonecrotic toxin of Bordetella pertussis strain 114 grown in chemically defined Stainer-Scholte medium was studied by using skin reaction in 4-day-old suckling mice as the assay for toxin. Through log phase and into stationary phase of growth the toxin was cell associated and not detected in the culture supernatant. Only about 4% of the activity present in a suspension of lysed cells was detected in a suspension of whole cells, and the dermonecrotic activity was not released by subjecting whole cells to osmotic shock, a procedure that releases proteins from the periplasmic space of many gram-negative bacteria. After cell lysis and preparation of soluble and membrane fractions, 73 to 80% of the activity in the cell lysate was recovered in the soluble fraction, with only 3 to 6% present in a membrane fraction. Further evidence for the intracellular cytoplasmic localization of the dermonecrotic toxin was the insensitivity of the toxin to trypsin treatment of whole cells. Treatment of whole cells with trypsin (80 micrograms/ml) for 20 min at 37 degrees C did not decrease dermonecrotic or malate dehydrogenase activities, but did inhibit more than 95% of the extra-cytoplasmic adenylate cyclase activity. Identical trypsin treatment of a cell lysate decreased all the above activities by more than 90%.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227787      PMCID: PMC414532          DOI: 10.1128/iai.25.3.896-901.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Antigens of Bordetella pertussis. II. Purification of heat-labile toxin.

Authors:  A BANERJEA; J MUNOZ
Journal:  J Bacteriol       Date:  1962-08       Impact factor: 3.490

2.  Some factors influencing the virulence for mice of Bordetella pertussis by the intracerebral route.

Authors:  A F STANDFAST
Journal:  Immunology       Date:  1958-04       Impact factor: 7.397

3.  Regulation of Bordetella pertussis extracytoplasmic adenylate cyclase.

Authors:  E L Hewlett; J Wolff; C R Manclark
Journal:  Adv Cyclic Nucleotide Res       Date:  1978

4.  Lienotoxicity of Bordetella pertussis in mice.

Authors:  T Iida; T Okonogi
Journal:  J Med Microbiol       Date:  1971-02       Impact factor: 2.472

5.  On the localization of alkaline phosphatase and cyclic phosphodiesterase in Escherichia coli.

Authors:  R W Brockman; L A Heppel
Journal:  Biochemistry       Date:  1968-07       Impact factor: 3.162

6.  Anaerobic L- -glycerophosphate dehydrogenase of Escherichia coli: its genetic locus and its physiological role.

Authors:  W S Kistler; E C Lin
Journal:  J Bacteriol       Date:  1971-12       Impact factor: 3.490

7.  Pathogenesis of infection with Bordetella pertussis in hamster tracheal organ culture.

Authors:  A M Collier; L P Peterson; J B Baseman
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

8.  Appearance of mouse-lethal toxin in liquid cultures of Bordetella pertussis.

Authors:  A G Lane
Journal:  Appl Microbiol       Date:  1968-09

9.  Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization.

Authors:  E Hewlett; J Wolff
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

10.  Extracytoplasmic adenylate cyclase of Bordetella pertussis.

Authors:  E L Hewlett; M A Urban; C R Manclark; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

View more
  27 in total

1.  Characterization of vir-activated TnphoA gene fusions in Bordetella pertussis.

Authors:  T M Finn; R Shahin; J J Mekalanos
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Purification and characterization of the heat-labile toxin of Bordetella pertussis.

Authors:  Y L Zhang; R D Sekura
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

Review 3.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

4.  Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp.

Authors:  G D Pullinger; T E Adams; P B Mullan; T I Garrod; A J Lax
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

5.  Islet-activating protein (pertussis toxin) diminishes alpha 2-adrenoceptor mediated effects on noradrenaline release.

Authors:  C Allgaier; T J Feuerstein; R Jackisch; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

6.  Lethal infection by Bordetella pertussis mutants in the infant mouse model.

Authors:  A A Weiss; M S Goodwin
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

Review 7.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

8.  Cloning of Bordetella pertussis outer membrane proteins in Escherichia coli.

Authors:  F Shareck; J Cameron
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

9.  Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation.

Authors:  S K Armstrong; C D Parker
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 10.  A cellular pertussis vaccine (Infanrix-DTPa; SB-3). A review of its immunogenicity, protective efficacy and tolerability in the prevention of Bordetella pertussis infection.

Authors:  S S Patel; A J Wagstaff
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.